Thomas Charles Reilly

Insider Reports History

Entity
Individual
Location
C/O Cara Therapeutics, Inc., 4 Stamford Plaza, 107 Elm Street, Stamford, CT
Signature
/s/ Tom Reilly
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Charles Reilly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AMARIN CORP PLC\UK EVP and CFO Ordinary Shares 94.3K $65.1K $0.69 Jul 1, 2024 Direct
Cara Therapeutics, Inc. Chief Financial Officer Common Stock 37.8K $46.1K $1.22 Mar 3, 2022 Direct
AMARIN CORP PLC\UK EVP and CFO Stock Option (right to buy) 418K Feb 1, 2024 Direct
Cara Therapeutics, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 40K Feb 25, 2022 Direct
AMARIN CORP PLC\UK EVP and CFO Restricted Stock Unit 16.7K Jul 1, 2024 Direct

Insider Reports Filed by Thomas Charles Reilly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AMRN AMARIN CORP PLC\UK Jul 1, 2024 3 -$5.66K 4 Jul 1, 2024 EVP and CFO
AMRN AMARIN CORP PLC\UK Jun 20, 2024 3 -$12K 4 Jun 21, 2024 EVP and CFO
AMRN AMARIN CORP PLC\UK Feb 1, 2024 2 $0 4 Feb 9, 2024 EVP and CFO
AMRN AMARIN CORP PLC\UK Jan 31, 2024 3 -$30.4K 4 Feb 2, 2024 EVP and CFO
AMRN AMARIN CORP PLC\UK Jan 10, 2024 4 -$27.5K 4 Jan 12, 2024 EVP and CFO
AMRN AMARIN CORP PLC\UK Jul 19, 2023 1 $437K 4 Jul 21, 2023 SVP and CFO
AMRN AMARIN CORP PLC\UK Jun 20, 2023 3 -$9.77K 4 Jul 5, 2023 SVP and CFO
AMRN AMARIN CORP PLC\UK Jun 20, 2023 3 -$19.5K 4 Jun 22, 2023 SVP and CFO
AMRN AMARIN CORP PLC\UK Feb 21, 2023 3 $0 4 Feb 23, 2023 SVP and CFO
AMRN AMARIN CORP PLC\UK Jul 1, 2022 2 $0 4 Jul 6, 2022 SVP and CFO
AMRN AMARIN CORP PLC\UK Jun 30, 2022 0 $0 3 Jul 6, 2022 SVP and CFO
CARA Cara Therapeutics, Inc. Mar 3, 2022 1 -$23.3K 4 Mar 4, 2022 Chief Financial Officer
CARA Cara Therapeutics, Inc. Feb 25, 2022 3 $54.9K 4 Mar 1, 2022 Chief Financial Officer
CARA Cara Therapeutics, Inc. Dec 17, 2021 1 $0 4 Dec 21, 2021 Chief Financial Officer
CARA Cara Therapeutics, Inc. Aug 30, 2021 1 -$28.1K 4 Sep 1, 2021 Chief Financial Officer
CARA Cara Therapeutics, Inc. Aug 24, 2021 1 $0 4 Aug 26, 2021 Chief Financial Officer